Pharmasset, Inc. HomepageSitemapContact Us
About Pharmasset Therapeutic Areas Our Product Candidates Investor Center Careers Contact Us
www.Pharmasset.com May 22, 2008 03:59 PM

Investor Relations

Press Releases

Events & Presentations

Corporate Governance

Financial Information

Stock Information

Investor FAQs

Contact Us

Shareholder Tools

Email Alerts


Search Investor Relations



Management

P. Schaefer Price, M.B.A.
President, Chief Executive Officer and Director
Kurt Leutzinger, C.P.A., M.B.A.
Executive Vice President and Chief Financial Officer
Michael J. Otto, Ph.D.
Chief Scientific Officer
Michael D. Rogers, Ph.D.
Chief Development Officer
Patrick T. Higgins, M.B.A
Executive Vice President, Marketing & Sales
Abel De La Rosa, Ph.D.
Senior Vice President, Business Development & Scientific Affairs
M. Michelle Berrey, M.D., M.P.H
Vice President, Clinical Development and Chief Medical Officer
Darryl Cleary, Ph.D.
Vice President, Manufacturing
Phillip A. Furman, Ph.D.
Vice President, Biological Sciences
Kevin A. Kucharski
Vice President, Clinical Operations
Mark W. Meester, C.P.A.
Vice President, Accounting & Administration
Alan S. Roemer, M.B.A., M.P.H.
Vice President, Investor Relations & Corporate Communications
Michael J. Sofia, Ph.D.
Vice President, Chemistry
William T. Symonds III, Pharm.D.
Vice President, Clinical Pharmacology
Pharmasset, Inc. Pharmasset, Inc. © 2008 . All Rights Reserved | Home | Top Return to Top
Site Design by Lakeshore Concepts